|
FY2026
12 months to Mar 31, 2026
|
FY2025
12 months to Mar 31, 2025
|
FY2024
12 months to Mar 31, 2024
|
|
|---|---|---|---|
| Operating expenses: | |||
| Research and development | |||
| Warrant expense - termination agreement | |||
| General and administrative | |||
| Total operating expenses | |||
| Loss from operations | |||
| Other income (expense): | |||
| Warrant liability - mark-to-market | |||
| Interest expense | |||
| Interest income | |||
| Total other income, net | |||
| Loss before income taxes | |||
| Income taxes | |||
| Net loss | |||
| Loss per share - basic and diluted (in dollars per share) | |||
| Weighted average shares outstanding - basic and diluted (in shares) |
Loading...
